Dr. Nicholas John Panella, MD

Dr. Panella practices at Tennessee Ear, Nose & Throat Consultants in Lenoir City, Tennessee.

Dr. Panella's NPI, 1023374238, was assigned on April 2, 2012. Dr. Panella holds Tennessee license 55947.

Dr. Panella's primary practice is Tennessee Ear, Nose & Throat Consultants, at 576 Ft Loudoun Medical Center Dr, Lenoir City, TN 37772 in Loudon County. The practice phone is (865) 693-6065.

Dr. Panella's primary practice is Tennessee Ear, Nose & Throat Consultants in Lenoir City, Tennessee. Dr. Panella is also affiliated with Covenant Health Fort Loudoun. The medical group on file is Ear, Nose & Throat Consultants of East Tennessee. Dmand AI also links Dr. Panella to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panella practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Panella's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Panella is licensed in Tennessee.

CMS data shows 2,135 Medicare services from Dr. Panella across 15 procedure codes in 2024, for 535 Medicare patients. Medicare paid $132,356 for them. Every service was in an office.

CMS counts 535 Medicare patients who saw Dr. Panella in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Panella's median patient age at 66, with 54% women.

In 2024, Dr. Panella wrote 769 Medicare Part D claims for 340 patients. 94% of them were for generic drugs. CMS names the drug for 655 of them, across 18 drugs with 11 or more claims each, at $23,239 in total drug cost. In 2023, CMS named 458 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Panella for performance year 2024, reported as part of a group. Dr. Panella accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of melanoma (skin cancer) excision by Dr. Panella, more than 64% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Panella, published from 2016 to 2018. 2016 was the busiest year, with 3. The most frequent topics are Sinusitis. Dr. Panella has published most often in Ann Otol Rhinol Laryngol. Dr. Panella's most frequent co-authors are Esther Ximena Vivas, MD, Kristen Lloyd Baugnon, MD and John M. Delgaudio, MD.

CMS Open Payments shows 206 general payments to Dr. Panella from 28 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 85% of the total. Aerin Medical Inc. paid the most, $1,109.